Insider Trading activities of Affymax Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Affymax Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Affymax Inc since year 2005. Table 2 shows the detailed insider transactions of Affymax Inc since 2005. The reporting company's ticker symbol is AFFY. The reporting company's CIK number is 1158223.
The total value of stock buying since 2005 is $10,049,791.
The total value of stock sales since 2005 is $94,792,084.
The total value of stock option exercises since 2005 is $7,482,008.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Affymax Inc (AFFY).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2013-08 0 $0 16,540 $31,822 0 $0
2013-02 0 $0 8,694 $156,428 8,694 $57,017
2013-01 0 $0 6,661 $141,559 6,661 $68,062
2012-12 0 $0 27,492 $645,543 27,492 $246,528
2012-11 0 $0 9,917 $227,353 8,861 $108,048
2012-10 0 $0 237,292 $5,815,860 226,674 $3,637,352
2012-09 0 $0 121,811 $2,454,945 120,898 $1,069,350
2012-08 0 $0 80,906 $1,402,634 73,430 $522,983
2012-07 0 $0 53,949 $842,657 36,536 $243,318
2012-06 0 $0 3,000 $39,300 3,000 $18,690
2012-05 0 $0 6,689 $94,876 3,000 $18,690
2012-04 0 $0 56,802 $728,691 3,000 $18,690
2012-03 0 $0 8,200 $128,740 8,200 $47,806
2012-02 0 $0 18,000 $180,000 0 $0
2011-12 16,540 $102,796 0 $0 0 $0
2011-11 0 $0 823 $4,254 0 $0
2011-08 0 $0 22,863 $104,701 0 $0
2011-07 0 $0 41,303 $282,140 0 $0
2011-06 0 $0 802,638 $5,634,511 0 $0
2011-05 0 $0 7,131 $50,130 0 $0
2011-01 0 $0 847,050 $6,094,922 0 $0
2010-08 0 $0 980,308 $7,652,633 0 $0
2010-05 0 $0 238,684 $6,046,853 235,806 $840,999
2010-04 0 $0 300 $7,500 300 $240
2010-03 0 $0 24,083 $503,009 24,083 $93,468
2010-02 0 $0 57,450 $1,083,389 52,935 $230,796
2009-11 0 $0 3,000 $60,810 3,000 $2,400
2009-09 0 $0 1,240,905 $27,021,583 140,905 $112,724
2009-05 0 $0 1,697 $29,629 0 $0
2009-03 652,262 $9,946,995 0 $0 0 $0
2008-05 0 $0 1,038 $16,089 0 $0
2007-12 0 $0 15,714 $395,629 15,714 $21,526
2007-11 0 $0 15,714 $441,047 15,714 $12,569
2007-10 0 $0 24,489 $657,846 24,489 $19,590
2007-09 0 $0 167,076 $25,815,001 113,954 $91,162

Table 2. Detailed insider stock purchases, sales, and option exercises of Affymax Inc insiders (AFFY)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-08-28 Walker John Peter Sale 16,540 1.92 31,822
2013-02-15 Knapp Jeffrey H (Chief Commercial Officer) Sale 2,328 15.76 36,684
2013-02-15 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 2,328 7.09 16,498
2013-02-01 Orwin John A (CEO) Sale 6,366 18.81 119,744
2013-02-01 Orwin John A (CEO) Option Ex 6,366 6.36 40,519
2013-01-15 Knapp Jeffrey H (Chief Commercial Officer) Sale 6,661 21.25 141,559
2013-01-15 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 6,661 10.22 68,062
2012-12-17 Knapp Jeffrey H (Chief Commercial Officer) Sale 6,694 22.31 149,316
2012-12-17 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 6,694 10.22 68,399
2012-12-14 Laporte Kathleen Sale 5,000 22.72 113,600
2012-12-14 Laporte Kathleen Option Ex 5,000 15.52 77,575
2012-12-03 Orwin John A (CEO) Sale 15,798 24.22 382,627
2012-12-03 Orwin John A (CEO) Option Ex 15,798 6.36 100,554
2012-11-23 Venteicher Robert (SVP, Technical Operations) Sale 833 24.00 19,992
2012-11-23 Venteicher Robert (SVP, Technical Operations) Option Ex 833 5.83 4,856
2012-11-19 Knapp Jeffrey H (Chief Commercial Officer) Sale 1,000 23.00 23,000
2012-11-19 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 1,000 21.74 21,740
2012-11-15 Knapp Jeffrey H (Chief Commercial Officer) Sale 5,833 22.62 131,942
2012-11-15 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 5,833 12.02 70,112
2012-11-02 Venteicher Robert (SVP, Technical Operations) Sale 1,195 23.63 28,237
2012-11-02 Venteicher Robert (SVP, Technical Operations) Option Ex 1,195 9.49 11,340
2012-11-01 Duliege Anne-marie (Chief Medical Officer) Sale 1,056 22.90 24,182
2012-10-23 Venteicher Robert (SVP, Technical Operations) Sale 833 25.74 21,441
2012-10-23 Venteicher Robert (SVP, Technical Operations) Option Ex 833 5.83 4,856
2012-10-15 Venteicher Robert (SVP, Technical Operations) Sale 42,173 27.00 1,138,671
2012-10-15 Venteicher Robert (SVP, Technical Operations) Option Ex 42,173 24.68 1,041,040
2012-10-15 Knapp Jeffrey H (Chief Commercial Officer) Sale 10,012 26.70 267,370
2012-10-15 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 10,012 14.89 149,078
2012-10-11 Venteicher Robert (SVP, Technical Operations) Sale 20,014 27.00 540,378
2012-10-11 Venteicher Robert (SVP, Technical Operations) Option Ex 20,014 24.68 494,045
2012-10-10 Venteicher Robert (SVP, Technical Operations) Sale 50,911 24.50 1,247,319
2012-10-10 Venteicher Robert (SVP, Technical Operations) Option Ex 50,911 13.39 681,698
2012-10-10 Duliege Anne-marie (Chief Medical Officer) Sale 9,704 24.00 232,896
2012-10-10 Knapp Jeffrey H (Chief Commercial Officer) Sale 15,014 25.50 382,857
2012-10-10 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 14,100 24.50 345,450
2012-10-09 Venteicher Robert (SVP, Technical Operations) Sale 10,938 23.00 251,574
2012-10-09 Venteicher Robert (SVP, Technical Operations) Option Ex 10,938 15.00 164,070
2012-10-09 Knapp Jeffrey H (Chief Commercial Officer) Sale 12,000 23.24 278,880
2012-10-09 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 12,000 21.74 260,879
2012-10-05 Orwin John A (CEO) Sale 41,664 22.50 937,440
2012-10-05 Orwin John A (CEO) Option Ex 41,664 6.90 287,481
2012-10-05 Venteicher Robert (SVP, Technical Operations) Sale 11,789 22.00 259,358
2012-10-05 Venteicher Robert (SVP, Technical Operations) Option Ex 11,789 10.99 129,561
2012-10-04 Venteicher Robert (SVP, Technical Operations) Sale 100 22.00 2,200
2012-10-04 Venteicher Robert (SVP, Technical Operations) Option Ex 100 10.99 1,099
2012-10-02 Venteicher Robert (SVP, Technical Operations) Sale 508 21.14 10,739
2012-10-02 Venteicher Robert (SVP, Technical Operations) Option Ex 508 7.99 4,058
2012-10-01 Orwin John A (CEO) Sale 11,632 21.04 244,737
2012-10-01 Orwin John A (CEO) Option Ex 11,632 6.36 74,037
2012-09-21 Venteicher Robert (SVP, Technical Operations) Sale 4,200 22.00 92,400
2012-09-21 Venteicher Robert (SVP, Technical Operations) Option Ex 4,200 13.00 54,579
2012-09-19 Venteicher Robert (SVP, Technical Operations) Sale 14,062 20.91 294,036
2012-09-19 Venteicher Robert (SVP, Technical Operations) Option Ex 14,062 6.91 97,168
2012-09-17 Knapp Jeffrey H (Chief Commercial Officer) Sale 6,662 20.76 138,269
2012-09-17 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 6,662 10.78 71,783
2012-09-13 Orwin John A (CEO) Sale 48,997 20.00 979,940
2012-09-13 Orwin John A (CEO) Option Ex 48,997 6.36 311,865
2012-09-13 Duliege Anne-marie (Chief Medical Officer) Sale 23,227 20.00 464,540
2012-09-13 Duliege Anne-marie (Chief Medical Officer) Option Ex 23,227 6.06 140,755
2012-09-13 Knapp Jeffrey H (Chief Commercial Officer) Sale 19,663 20.00 393,260
2012-09-13 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 18,750 18.84 353,250
2012-09-05 Cross Herb (Chief Financial Officer) Sale 5,000 18.50 92,500
2012-09-05 Cross Herb (Chief Financial Officer) Option Ex 5,000 7.99 39,950
2012-08-20 Orwin John A (CEO) Sale 48,996 17.50 857,430
2012-08-20 Orwin John A (CEO) Option Ex 48,996 6.36 311,859
2012-08-20 Knapp Jeffrey H (Chief Commercial Officer) Sale 21,567 17.50 377,422
2012-08-20 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 18,750 8.81 165,243
2012-08-15 Knapp Jeffrey H (Chief Commercial Officer) Sale 4,584 16.48 75,530
2012-08-15 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 4,584 8.61 39,468
2012-08-13 Knapp Jeffrey H (Chief Commercial Officer) Sale 4,659 15.95 74,311
2012-08-01 Orwin John A (CEO) Sale 1,100 16.31 17,941
2012-08-01 Orwin John A (CEO) Option Ex 1,100 5.83 6,413
2012-07-17 Cross Herb (Chief Financial Officer) Sale 10,000 17.00 170,000
2012-07-17 Cross Herb (Chief Financial Officer) Option Ex 10,000 6.23 62,300
2012-07-16 Knapp Jeffrey H (Chief Commercial Officer) Sale 4,584 16.29 74,682
2012-07-16 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 4,584 8.61 39,468
2012-07-13 Orwin John A (CEO) Sale 18,700 15.00 280,500
2012-07-13 Orwin John A (CEO) Option Ex 2,200 5.83 12,826
2012-07-13 Knapp Jeffrey H (Chief Commercial Officer) Sale 5,665 15.00 84,975
2012-07-13 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 4,752 10.99 52,224
2012-07-13 Cross Herb (Chief Financial Officer) Sale 15,000 15.50 232,500
2012-07-13 Cross Herb (Chief Financial Officer) Option Ex 15,000 5.10 76,500
2012-06-15 Knapp Jeffrey H (Chief Commercial Officer) Sale 3,000 13.10 39,300
2012-06-15 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 3,000 6.23 18,690
2012-05-25 Duliege Anne-marie (Chief Medical Officer) Sale 3,689 14.11 52,051
2012-05-15 Knapp Jeffrey H (Chief Commercial Officer) Sale 3,000 14.28 42,825
2012-05-15 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 3,000 6.23 18,690
2012-04-27 Orwin John A (CEO) Sale 30,000 13.35 400,620
2012-04-27 Venteicher Robert (SVP, Technical Operations) Sale 5,474 13.23 72,421
2012-04-24 Knapp Jeffrey H (Chief Commercial Officer) Sale 2,414 12.50 30,175
2012-04-24 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 1,500 6.23 9,345
2012-04-16 Knapp Jeffrey H (Chief Commercial Officer) Sale 2,414 11.86 28,630
2012-04-16 Knapp Jeffrey H (Chief Commercial Officer) Option Ex 1,500 6.23 9,345
2012-04-03 Orwin John A (CEO) Sale 16,500 11.93 196,845
2012-03-27 Orwin John A (CEO) Sale 8,200 15.70 128,740
2012-03-27 Orwin John A (CEO) Option Ex 8,200 5.83 47,806
2012-02-02 Orwin John A (CEO) Sale 18,000 10.00 180,000
2011-12-19 Walker John Peter Buy 16,540 6.22 102,796
2011-11-01 Duliege Anne-marie (Chief Medical Officer) Sale 823 5.17 4,254
2011-08-18 Orwin John A (CEO) Sale 12,000 4.55 54,600
2011-08-17 Duliege Anne-marie (Chief Medical Officer) Sale 5,296 4.73 25,050
2011-08-15 Venteicher Robert (SVP, Technical Operations) Sale 5,567 4.50 25,051
2011-07-01 Laporte Kathleen (Director) Sale 41,303 6.83 282,140
2011-06-30 Laporte Kathleen (Director) Sale 51,797 6.90 357,606
2011-06-28 Laporte Kathleen (Director) Sale 746,818 7.03 5,250,877
2011-06-23 Duliege Anne-marie (Chief Medical Officer) Sale 4,023 6.47 26,028
2011-05-16 Laporte Kathleen (Director) Sale 7,131 7.03 50,130
2011-01-14 Laporte Kathleen (Director) Sale 47,541 7.00 333,024
2011-01-13 Laporte Kathleen (Director) Sale 17,200 7.00 120,486
2011-01-12 Laporte Kathleen (Director) Sale 250,000 7.09 1,772,500
2011-01-11 Laporte Kathleen (Director) Sale 450,000 7.22 3,248,550
2011-01-10 Laporte Kathleen (Director) Sale 82,309 7.54 620,362
2010-08-10 Laporte Kathleen (Director) Sale 80,308 7.58 608,333
2010-08-09 Laporte Kathleen (Director) Sale 450,000 7.83 3,522,150
2010-08-09 Credit Suisse Ag/ Sale 450,000 7.83 3,522,150
2010-05-18 Morris Arlene (CEO) Sale 51,830 25.06 1,299,067
2010-05-18 Morris Arlene (CEO) Option Ex 51,830 6.57 340,523
2010-05-17 Morris Arlene (CEO) Sale 1,066 25.00 26,655
2010-05-17 Morris Arlene (CEO) Option Ex 1,066 4.36 4,647
2010-05-13 Morris Arlene (CEO) Sale 41,021 25.05 1,027,411
2010-05-13 Morris Arlene (CEO) Option Ex 41,021 4.36 178,851
2010-05-12 Morris Arlene (CEO) Sale 109,308 25.72 2,811,948
2010-05-12 Morris Arlene (CEO) Option Ex 109,308 2.58 282,014
2010-05-11 Morris Arlene (CEO) Sale 30,081 25.01 752,325
2010-05-11 Morris Arlene (CEO) Option Ex 30,081 .80 24,064
2010-05-04 Duliege Anne-marie (Chief Medical Officer) Sale 4,197 24.07 101,021
2010-05-04 Duliege Anne-marie (Chief Medical Officer) Option Ex 2,500 4.36 10,900
2010-05-04 Love Steven (Vice President, Finance) Sale 1,181 24.07 28,426
2010-04-23 Morris Arlene (CEO) Sale 300 25.00 7,500
2010-04-23 Morris Arlene (CEO) Option Ex 300 .80 240
2010-03-16 Duliege Anne-marie (Chief Medical Officer) Sale 2,500 20.96 52,400
2010-03-16 Duliege Anne-marie (Chief Medical Officer) Option Ex 2,500 .80 2,000
2010-03-15 Duliege Anne-marie (Chief Medical Officer) Sale 21,583 20.88 450,609
2010-03-15 Duliege Anne-marie (Chief Medical Officer) Option Ex 21,583 4.24 91,468
2010-02-25 Cleveland Paul B (EVP, Corp. Development and CFO) Sale 55,935 18.82 1,052,696
2010-02-25 Cleveland Paul B (EVP, Corp. Development and CFO) Option Ex 52,935 4.36 230,796
2010-02-23 Love Steven (Vice President, Finance) Sale 1,515 20.26 30,693
2009-11-10 Duliege Anne-marie (Chief Medical Officer) Sale 3,000 20.27 60,810
2009-11-10 Duliege Anne-marie (Chief Medical Officer) Option Ex 3,000 .80 2,400
2009-09-28 Morris Arlene (President and CEO) Sale 101,100 25.00 2,527,500
2009-09-28 Morris Arlene (President and CEO) Option Ex 101,100 .80 80,880
2009-09-16 Apax Europe V Gp Co.ltd (10% Owner) Sale 56,599 21.62 1,223,670
2009-09-16 Apax Managers Inc (10% Owner) Sale 43,401 21.62 938,329
2009-09-14 Apax Europe V Gp Co.ltd (10% Owner) Sale 169,795 21.00 3,565,695
2009-09-14 Apax Managers Inc (10% Owner) Sale 130,205 21.00 2,734,305
2009-09-11 Apax Europe V Gp Co.ltd (10% Owner) Sale 226,394 21.00 4,754,274
2009-09-11 Apax Managers Inc (10% Owner) Sale 173,606 21.00 3,645,726
2009-09-03 Duliege Anne-marie (Chief Medical Officer) Sale 3,250 22.00 71,500
2009-09-03 Duliege Anne-marie (Chief Medical Officer) Option Ex 3,250 .80 2,600
2009-09-01 Duliege Anne-marie (Chief Medical Officer) Sale 30,000 24.06 721,710
2009-09-01 Duliege Anne-marie (Chief Medical Officer) Option Ex 30,000 .80 24,000
2009-09-01 Morris Arlene (President and CEO) Sale 6,555 25.00 163,875
2009-09-01 Morris Arlene (President and CEO) Option Ex 6,555 .80 5,244
2009-09-01 Apax Europe V Gp Co.ltd (10% Owner) Sale 169,795 22.25 3,777,938
2009-09-01 Apax Managers Inc (10% Owner) Sale 130,205 22.25 2,897,061
2009-05-01 Duliege Anne-marie (Chief Medical Officer) Sale 1,697 17.46 29,629
2009-03-02 Credit Suisse/ (10% Owner) Buy 652,262 15.25 9,946,995
2008-05-15 Duliege Anne-marie (Chief Medical Officer) Sale 1,038 15.50 16,089
2007-12-03 Morris Arlene (President and CEO) Sale 8,163 25.14 205,201
2007-12-03 Morris Arlene (President and CEO) Option Ex 8,163 .80 6,530
2007-12-03 Naso Robert B (EVP, Research and Development) Sale 7,551 25.22 190,428
2007-12-03 Naso Robert B (EVP, Research and Development) Option Ex 7,551 1.99 14,996
2007-11-06 Morris Arlene (President and CEO) Sale 6,487 27.95 181,311
2007-11-06 Morris Arlene (President and CEO) Option Ex 6,487 .80 5,189
2007-11-05 Morris Arlene (President and CEO) Sale 1,676 28.25 47,350
2007-11-05 Morris Arlene (President and CEO) Option Ex 1,676 .80 1,340
2007-11-01 Naso Robert B (EVP, Research and Development) Sale 7,551 28.13 212,386
2007-11-01 Naso Robert B (EVP, Research and Development) Option Ex 7,551 .80 6,040
2007-10-03 Morris Arlene (President and CEO) Sale 16,326 26.86 438,564
2007-10-03 Morris Arlene (President and CEO) Option Ex 16,326 .80 13,060
2007-09-19 Naso Robert B (EVP, Research and Development) Sale 32,953 27.28 900,772
2007-09-19 Naso Robert B (EVP, Research and Development) Option Ex 32,953 .80 26,362
2007-09-18 Naso Robert B (EVP, Research and Development) Sale 15,300 27.28 417,782
2007-09-18 Naso Robert B (EVP, Research and Development) Option Ex 15,300 .80 12,240
2007-09-17 Naso Robert B (EVP, Research and Development) Sale 10,000 27.75 277,500
2007-09-17 Naso Robert B (EVP, Research and Development) Option Ex 10,000 .80 8,000
2007-09-12 Morris Arlene (President and CEO) Sale 10,727 27.84 298,639
2007-09-12 Morris Arlene (President and CEO) Option Ex 10,727 .80 8,581
2007-09-11 Morris Arlene (President and CEO) Sale 12,000 2,219.64 10,994,011
2007-09-11 Morris Arlene (President and CEO) Option Ex 12,000 .80 9,600
2007-09-10 Morris Arlene (President and CEO) Sale 8,000 25.20 201,624
2007-09-10 Morris Arlene (President and CEO) Option Ex 8,000 .80 6,400
2007-09-07 Morris Arlene (President and CEO) Sale 13,000 25.08 325,975
2007-09-07 Morris Arlene (President and CEO) Option Ex 13,000 .80 10,400
2007-09-06 Morris Arlene (President and CEO) Sale 12,000 25.19 302,292
2007-09-06 Morris Arlene (President and CEO) Option Ex 11,974 .80 9,579
2007-09-05 Morris Arlene (President and CEO) Sale 6,716 25.00 167,900
2007-09-04 Morris Arlene (President and CEO) Sale 7,967 25.00 199,175

Insider trading activities including stock purchases, stock sales, and option exercises of AFFY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Affymax Inc (symbol AFFY, CIK number 1158223) see the Securities and Exchange Commission (SEC) website.